Scholarlink

Background <p>Helicobacter pylori (<i>H. pylori</i>) infection is linked to various gastrointestinal and systemic diseases, including diabetes mellitus (DM). This study synthesizes evidence to determine the association between <i>H. pylori</i> infection and the risk of developing DM.</p> Objectives <p>To quantify the odds ratio (OR) of DM in individuals with <i>H. pylori</i> infection and explore variations across different subgroups.</p> Methods <p>A systematic review and meta-analysis were conducted following PRISMA 2020 guidelines. Databases including Medline, Web of Science, Scopus, EMBASE, Ovid, and CINHAL were searched for case-control studies from January 1990 to January 2025. Eligible studies investigated the association between <i>H. pylori</i> and DM. Data extraction was performed independently by two reviewers, and study quality was assessed using the Modified Newcastle-Ottawa Scale (NOS). Random-effects models were utilized to calculate pooled ORs, with heterogeneity assessed via I² statistic. Subgroup analyses included <i>H. pylori</i> detection methods, age groups, geographic regions, DM types, HbA1c levels, duration of DM, and study quality.</p> Results <p>From 280 records, 45 case-control studies were included, involving 529&#xa0;million diabetes cases worldwide in 2021. The pooled OR was 1.547 (95% CI: 1.243–1.926), indicating that <i>H. pylori</i> infection increases the risk of DM by approximately 1.56 times. Heterogeneity was moderate (I² = 46.03%). Subgroup analyses showed stronger associations with non-invasive <i>H. pylori</i> detection methods (OR = 1.99), in the 40–60 age group (OR = 2.00), and for type 2 diabetes (OR = 2.25). Geographic variations were significant, with Asia showing the highest OR (2.17). No significant publication bias was detected, and sensitivity analyses confirmed the robustness of our findings.</p> Conclusion <p>This meta-analysis confirms a significant association between <i>H. pylori</i> infection and an increased risk of DM, particularly type 2. The findings underscore the potential benefits of considering <i>H. pylori</i> testing in diabetes management strategies, especially in high-risk populations. Further research should focus on longitudinal studies to establish causality and explore biological mechanisms.</p> Registration <p>This review was registered in PROSPERO (CRD42025637126).</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The association between Helicobacter pylori infection and diabetes mellitus: an updated meta-analysis of 45 case-control studies

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月29日

查看全文
  • Hooman Hadianfard,
  • Ramyar Rahimi Darehbagh,
  • Kimya Ahmadpooryan,
  • Parvin Mohamadi,
  • Yousef Moradi

摘要

Background

Helicobacter pylori (H. pylori) infection is linked to various gastrointestinal and systemic diseases, including diabetes mellitus (DM). This study synthesizes evidence to determine the association between H. pylori infection and the risk of developing DM.

Objectives

To quantify the odds ratio (OR) of DM in individuals with H. pylori infection and explore variations across different subgroups.

Methods

A systematic review and meta-analysis were conducted following PRISMA 2020 guidelines. Databases including Medline, Web of Science, Scopus, EMBASE, Ovid, and CINHAL were searched for case-control studies from January 1990 to January 2025. Eligible studies investigated the association between H. pylori and DM. Data extraction was performed independently by two reviewers, and study quality was assessed using the Modified Newcastle-Ottawa Scale (NOS). Random-effects models were utilized to calculate pooled ORs, with heterogeneity assessed via I² statistic. Subgroup analyses included H. pylori detection methods, age groups, geographic regions, DM types, HbA1c levels, duration of DM, and study quality.

Results

From 280 records, 45 case-control studies were included, involving 529 million diabetes cases worldwide in 2021. The pooled OR was 1.547 (95% CI: 1.243–1.926), indicating that H. pylori infection increases the risk of DM by approximately 1.56 times. Heterogeneity was moderate (I² = 46.03%). Subgroup analyses showed stronger associations with non-invasive H. pylori detection methods (OR = 1.99), in the 40–60 age group (OR = 2.00), and for type 2 diabetes (OR = 2.25). Geographic variations were significant, with Asia showing the highest OR (2.17). No significant publication bias was detected, and sensitivity analyses confirmed the robustness of our findings.

Conclusion

This meta-analysis confirms a significant association between H. pylori infection and an increased risk of DM, particularly type 2. The findings underscore the potential benefits of considering H. pylori testing in diabetes management strategies, especially in high-risk populations. Further research should focus on longitudinal studies to establish causality and explore biological mechanisms.

Registration

This review was registered in PROSPERO (CRD42025637126).